Menu
| 13:00 – 14:00 | Basic Notions of Risc management | Dr. Renata Zahu, Amethyst Radiotherapy Cluj |
| Incident reporting in Radiotherapy | Dr. Daniela Martin, Institute of Oncology Cluj Napoca | |
| Quality control in radiotherapy | Exp Fiz. Florin Costache, Sf Nectarie Oncology Center, Craiova | |
| Free Discussion on the subject: “Factors threatening safety culture and safety in a radiotherapy department” | Dr. Renata Zahu, Dr. Daniela Martin, Exp. Fiz. Florin Costache |
| 14:00 – 14:10 | Principles of tomotherapy. Fundaments and clinical cases | Voina Eliza |
| 14:10 – 14:20 | Clinical applications of tomotheraphy | Voina Eliza |
| 14:20 – 14:30 | Motion Management in radiotherapy | Diviricean Radu |
| 14:30 – 14:40 | The management of oncological patient during pandemic period in Radiotherapy Department of “Sf. Apostol Andrei” Emergency Clinical Hospital Galati | Georgeta Druțu, Magdalena Martiș, Theodora Daniela Preda |
| 14:40 – 14:50 | Patient preparatory coaching | Diviricean Radu |
| 14:50 – 15:00 | Pediatric radiation therapy | Vincze Noemi Kinga, Pop Carla, Diviricean Radu |
| 15:00 – 15:10 | Care and management of patients with indications for 3D interstitial brachytherapy | Ancuța Elena Baciu, Mădălina Croitoriu, Simona Lupu, Diana Cipu, Alexandru Oprea, Amalia Constantinescu, Raluca Vasile, Maria Mihai |
| 15:10 – 15:20 | Tumors with indications for radiotherapy | Valentin Grosu, Angela Grosu, Violeta Drăgan |
| 15:20 – 15:30 | Basic principles in radiotherapy of cervical neoplasm | Colița Andrei, Vizitiu Claudiu, Iancu Florin |
| 15:30 – 15:40 | The principles of radiotherapy in oncology | Ivasc Veronel, Ivasc Lenuța, Vasile Raluca |
| 15:40 – 15:50 | MRI guided Radipotherapy | Ene Steluța, Pană Teodor |
| 15:50 – 16:00 | Malignant melanoma – the most common types in histopathology | Alexe Gheorghe, Stan Paulina, Sharifi Cristina Carmen, Mocanu Mariana |
| 16:00 – 16:10 | Case study – Keratocanthoma and Angiolipoma, two soft tissue tumor formations | Alexe Liliana, Neata Elena, Dragoescu Angela |
| 16:10 – 16:20 | The role of neuroendocrine scintigraphy in the diagnosis of pathological lesions in which somatostatin receptors are overexpressed | Anton Iuliana, Nita Constanța, Dumitrache Mihaela |
| 16:20 – 16:40 | Break | |
| 16:40 – 16:50 | Psychosocial factors and psychoneuroimmunological mechanisms involved in cancer regulation | Văduva Florica, Ionescu Florina, Stroe Mariana, Marin Adriana |
| 16:50 – 17:00 | Treatment of endometrial cancer | Ionescu Florina, Stan Mariana, Ciobanu Constanța |
| 17:00 – 17:10 | Ulcers in palliation in oncological patients | Matei Gianina, Vasile Mihaela, Ghica Laura |
| 17:10 – 17:20 | Communication with the patient in the care process | Birladeanu Cristina, Moraru Mariana, Chivu Iuliana |
| 17:20 – 17:30 | Pain therapy for terminal cancer patients | Martinescu Georgiana, Albisoru Mirela, Petre Georgiana, Sarb Daniela |
| 17:30 – 17:40 | Surprise your cancer! Radiotherapy saves lives | Feraru Andreea, Stămulescu Raluca |
| 17:40 – 17:50 | Screening methods and risk factors in breast cancer | Matei Daniela, Frățiloiu Mirela |
| 17:50 – 18:00 | Ways to prevent cancer | Neacsu Daniela, Serban Meri |
| 18:00 – 18:10 | The psycho-emotional impact on the medical team in the care of the patient with advanced osteosarcoma | Dumitrașcu Giliola, Muszka Valentina, Vizitiu Claudiu |
| 18:10 – 18:20 | The role of the implantable camera in the administration of cytostatic treatment | Goleanu Mihaela, Berdila Aurelia, Gherase Raluca, Neacsa Mirela |
| 18:20 – 18:40 | The impact of stress on the oncology patient versus the medical staff | Simion Anisoara, Mihaila Diana, Ursu Ana Maria, Boboc Adriana |
| 18:40 – 18:50 | Integrating the need for the appearance of religious worship in terminal patients in palliative care | Pana Doina, Musat Denisa, Mitu Robert, Vlad Simona |
| 18:50 – 19:00 | Harmful emotions? Relaxation methods? Yes! There are! | Buflea Mihaela, Bogdan Costinela, Dobrescu Mihaela, Lazarescu Adriana |
| 19:00 – 19:10 | Care of patients with venous thrombosis | Trusca Nicoleta Veronica, Alexandru Mariana, Tone Rebeca Mihaela, Catrinoiu Ioana |
| 19:10 – 19:20 | The rights of children with cancer in Romania | Eftene Gianina, Mitu Daniela, Mihaila Diana, Macovei Mihaela |
| 19:20 – 19:30 | Palliative care for children with cancer | Dobre Olguta, Olar Irina Loredana, Giurea Cristina, Radu Alexandrina |
| 19:30 – 19:40 | Communication between the medical assistant and the patient | Ciofu Ionela, Tuicu Catalina |
| 14:15 – 14:30 | Education in Medical Physics, present and future | Lect. Dr. Mihaela-Tinca Udristioiu, Departamentul de Fizica, Universitatea din Craiova |
| 14:30 – 14:45 | Imaging methods used in inferior venous system evaluation: Angiography versus Phlebography | D. A. Grunzu (Lipșa), Facultatea de Bioinginerie Medicala, Universitatea “Gr.T. Popa” Iasi |
| 14:45 – 15:00 | The importance of CT and MRI imaging explorations in the nephroblastomas stagins process | Roxana Ciobanu, Spitalul Clinic de Urgenta pentru Copii “Sf.Maria” Iasi |
| 15:00 – 15:15 | The importance of medical imaging in radiotherapy treatment plan implementation for brain tumors | Valentina Sabie (Nastas), Neolife Medical Center Iasi |
| 15:15 – 15:30 | Professional exposure methods for pregnant workers in an Angiography Laboratory | D. A. Grunzu (Lipșa), Facultatea de Bioinginerie Medicala, Universitatea “Gr.T. Popa” Iasi |
| 15:30 – 15:45 | The physics aspect of interstitial IGBT implementation – focus on MRI | Pop Diana, Institutul Oncologic “Prof.Dr. Ion Chiricuta” Cluj-Napoca |
| 15:45 – 16:00 | Traceability and Dosimetry for soft tissue sarcoma of the leg using 3D interstitial Brachytherapy | Madalina CROITORIU, Ancuta Elena BACIU, Simona LUPU, Diana Cipu, Amalia CONSTANTINESCU, Dr. Serban MARINESCU, Ana-Maria GALCA, Costina DIACONU, Georgiana CHIRT, Maria MIHAI, Institutul Oncologic ,,Prof. Dr. Alexandru Trestioreanu” Bucuresti |
| 16:00 – 16:15 | 3D Interstitial Brachytherapy for soft tissue tumors of the eyelids (Malt Non-Hodgkin Lymphoma) | Simona Lupu, Diana Cipu, Ancuta Elena Baciu, Madalina Croitoriu, Amalia Constantinescu, Mircea Savu, Alexandru Oprea, Elisabeta Gabriela Murgoi, Maria Mihai, Institutul Oncologic ,,Prof. Dr. Alexandru Trestioreanu” Bucuresti |
| 16:15 – 16:30 | Factors impacting on patient setup analysis and error management during breast cancer radiotherapy | Ioana-Claudia Costin(1,2), Loredana G. Marcu (1,3,4), 1.Universitatea de Vest Timișoara, Facultatea de Fizică, Timișoara, 2.Spitalul Clinic „Dr. Gavril Curteanu” , Oradea, 3. Facultatea de Informatică și Științe, Universitatea din Oradea, 4.Cancer Research Institute, University of South Australia, Adelaide, Australia |
| 16:30 – 16:45 | Break | |
| 16:45 – 17:00 | Dosimetric comparison of LH in FB versus DIBH | Alexandru Farcasanu, Andrea-Larisa Eva, Centrul Amethyst Cluj |
| 17:00 – 17:15 | Different treatment planning strategies in Prostate SBRT | Nadir Kucuk, Anadolu Medical Center Turkey |
| 17:15 – 17:30 | A multicenter pilot study based on IAEA end-to-end IMRT/VMAT audit methodology using a Cirs Shane Phantom | Andreea A. UDREA1,2,*, Mihai T. DUMITRACHE1, Alina DUMITRACHE1, Maria VLĂSCEANU1 1Emergency Central Military Hospital ”Dr. Carol Davila”, Bucharest, Romania 2University of Bucharest, Faculty of Physics, Măgurele, Romania |
| 17:30 – 17:45 | Comparison between the Anisotropic Analytical Calculation Algorithm (AAA) and the Acuros XB Calculation Algorithm for lung tumors VMAT | FLORIN COSTACHE, MARIA ANDREEA FERARU, BIANCA MIHAELA COTOI, Centrul de Radioterapie “Sfantul Nectarie” Craiova |
| 17:45 – 18:00 | Gamma analysis and treatment plan acceptance criteria definition for quality assurance in VMAT – case study | Monica G. BĂRĂNESCU, Mihai T. DUMITRACHE, Adriana CÎRJAN, Cristina RISTEA, SPITALUL ONCOFORT, GRAL MEDICAL, BUCURESTI |
| 18:00 – 18:15 | Q&A Session | |
| 18:15 – 19:00 | Romanian Society of Medical Physics – General Assembley | Calin Buzea, RSMF President |
| 14:00 – 14:10 | Cuvant Deschidere – Dr. Claudia Ordeanu, organizator curs | |
| 14:10 – 14:40 | The status of brachytherapy in Romania | Dr. Ștefanel Vlad |
| 14:40 – 15:10 | Gynecological brachytherapy applicators and dose reporting – historical perspectives | Dr. Savu Mircea |
| 15:10 – 15:30 | Tips and tricks in CT guided IGABT with Hybrid Technique | Dr. Beatrice Anghel |
| 15:30 – 16:00 | LDR vs HDR for prostate cancer brachytherapy | Prof. Dr. Kacso Gabriel |
| 16:00 – 16:20 | LDR vs HDR for prostate cancer- the physicist perspective | Exp. Fiz. Med. Dordai Dan |
| 16:20 – 16:40 | Break | |
| 16:40 – 17:00 | Satellite Symposium Varian – Brachytherapy Innovations from Varian | Eleonora Jovceva |
| 17:00 – 17:20 | Indications of modern brachytherapy for breast cancer | Dr. Bujor Laurentiu |
| 17:20 – 17:40 | The transition from 2D to 3D image guided brachytherapy in gynecological cancer treatment | Dr. Coza Ovidiu |
| 17:40 – 18:00 | Difficulties of implementing brachytherapy at the Clinical Emergency County Hospital Oradea | Dr. Pătcaș Elisabeta |
| 18:00 – 18:20 | Image guided adaptive brachytherapy in cervical cancer | Dr. Manea Elena |
| 18:20 – 18:40 | The evolution of gynecological brachytherapy at IOCN | Dr. Ordeanu Claudia |
| 18:40 – 19:00 | Physics aspects of MRI/CT guided brachytherapy | Fiz. Med. Pop Diana |
| 14:00 – 14:10 | The role of oncological treatment in benign brain tumors – case presentation | Țurcaș Adrian |
| 14:10 – 14:20 | Radiotherapy in patients following mastectomy with immediate reconstruction. Dosimetric considerations. | Coord: Dr. Martin Daniela, Rez. Dr. Țîpcu Alexandru, Rez. Dr. Deac Ligia Maria |
| 14:20 – 14:30 | Combining immunotherapy with radiotherapy – changes the “paradigm” of target volumes and organs at risk (OAR’s) | Camil Ciprian Mirestean, Roxana Irina Iancu, Dragos Teodor Iancu |
| 14:30 – 14:40 | Atypical supurative evolution in a patient with advanced squamous carcinoma of the lung with second line nivolumab | Alex Kacso |
| 14:40 – 14:50 | Clinical Determinants and Chemo-Radiotoxicity Impact on Clinical Evolution of Cervical Cancer Patients during Treatment | A. Folea, L. Bîlteanu, F. Alis, V. Moga, D. Dragomir, A. Grigoras, R.V. Toma, R. Anghel |
| 14:50 – 15:00 | Quantitative Assessment of Hematological Side-effects in Multimodal Treatment of Cervical Cancer Patients | V. Moga, L. Bîlteanu, F. Alis, D. Dragomir, A. Folea, A. Grigoras, R.V. Toma, R. Anghel |
| 15:00 – 15:10 | Dosimetric Differences and Immediate Post-treatment Efficacy of Radiotreatment Modes in Cervical Cancer: 3D vs. VMAT | A. Grigoras, L. Bîlteanu, F. Alis, V. Moga, D. Dragomir, R.V. Toma, R. Anghel |
| 15:10 – 15:20 | Pre-conditioning of Cardiac Events after Multimodal Treatment of Breast Cancer Patients | D. Dragomir, L. Bîlteanu, I. Vîrtosu, V. Moga, A. Folea, A. Grigoras, A. Sandu, R.V. Toma, R. Anghel |
| 15:20 – 15:30 | Long term follow-up of patients with stage II and III bladder cancer | Mihai Paun, Ana Ciornei Bogdan Bogatu, Luiza Serbanescu, Laurentia Gales, Rodica Anghel, Oana Trifanescu |
| 15:30 – 15:40 | Role of multimodal treatment in esophageal cancer | Bogdan Bogatu, Mihai Paun, Ana Ciornei, Luiza Serbanescu,Toma Radu Valeriu, Laurentia Gales, Rodica Anghel, Oana Trifanescu |
| 15:40 – 15:50 | Leptomeningeal metastasis in HER2 breast cancer- current standard of treatment and new treatment options | Ana Ciornei, Mihai Paun, Bogdan Bogatu, Luiza Serbanescu, Oana Trifanescu Laurentia Gales, Rodica Anghel |
| 15:50 – 16:00 | The role of databases in the generation of scientific hypotheses | Iordache Diana, Fekete Zsolt, Balacescu Ovidiu |
| 16:00 – 16:10 | Correlation of serum calcium at the diagnosis of prostate cancer with tumor recurrence | Nuțu Dumitrița, Henrietta Jakab, Fekete Zsolt, Todor Nicolae, Laszlo Istvan, Cebotaru Cristina, Prof. Dr. Kacso Gabriel |
| 16:10 – 16:20 | Multimodal Treatment in Metastatic RCC – case presentation | Elena Șerban |
| 16:20 – 16:40 | Break | |
| 16:40 – 16:50 | A Complex THERAPEUTIC SEQUENCE IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER | Galoș Diana |
| 16:50 – 17:00 | Stage IV Bronchial Carcinoid’s Variability in Response to Multimodal Therapy: Case Report | Alexandru Ioan Băjenaru, Laura Predescu, Mirela Gherghe |
| 17:00 – 17:10 | Education in radiation oncology – focus on research – proposal for a multicenter questionnaire study | Mireștean Camil Ciprian |
| 17:10 – 17:20 | Implications of surgical treatment of bronchopulmonary cancer. Treatment in bronchopleural fistula, a post pneumonectomy and chemotherapy complication. | Dr. Crimu Maria-Catalina |
| 17:20 – 17:30 | Particular aspects of radiotherapy in paediatric and AYA patients | Andrada Turcas, Sarah M Kelly, Cernea Dana, Henry Mandevile |
| 17:30 – 17:40 | Quality Assurance in Pediatric Radiotherapy Clinical Trials | |
| 17:40 – 17:50 | The Place of Radiotherapy in the Multidisciplinary Treatment of Mycosis Fungoides- Case Report and Review of the Literature | Claudia-Elena Pavel, Nadejda Corobcean, Conf. Dr. Laura Florentina Rebegea |
| 17:50 – 18:00 | Diagnosis and treatment management of multiple primary malignant tumors in a patient with 3 neoplastic locations – case report and review of literature data | Nadejda Corobcean,Claudia-Elena Pavel,Ana-Maria Ilie, Conf. Dr. Laura-Florentina Rebegea |
| 18:00 – 18:10 | PATIENT SELECTION IN REIRRADIATION OF HEAD AND NECK CANCER IN THE ERA OF VOLUMETRIC MODULATED ARC THERAPY – LITERATURE REVIEW | Dr. Iordăchel Ioana, Prof. Dr. Anghel Rodica |
| 18:10 – 18:20 | Embryonal testicular carcinoma of an 18-years-old patient. Does it sound as a common case report? | Stancu Andra-Maria, Petruta-Raluca Tui, Pantelimon Iuliana |
| 18:20 – 18:30 | Blood Type Association with Head and Neck Cancer | Alexandru Michire, Alexandra Gaube, Filip-Stefan Calangiu, Mihnea Gabriel Burlacu, Petruta-Maria Michire, Mihai-Teodor Georgescu |
| 18:30 – 18:40 | Treatment evolution and response for oncological patients following SARS-CoV2 infection | Trifănescu Oana Gabriela, Laurenția Galeș, Serbănescu Luiza, Xenia Bacinschi, Georgescu Mihai, Sandu Alexandra, Michire Alexandru, Pavel Cristian, Vîrtosu Ion, Anghel Rodica |
| 18:40 – 18:50 | COEXISTENCE OF NEUROFIBROMATOSIS TYPE 1 AND INVASIVE BREAST CARCINOMA OF A 35-YEARS-OLD PATIENT: CASE REPORT. | Țui Petruța-Raluca, Stancu Andra-Maria, Pantelimon Iuliana |
| 18:50 – 19:00 | Irradiation of the subventricular zone in glioblastoma | Otilia Ciobanu, Gabriel Kacso |
| 08:45 – 09:05 | Updates in non-metastatic melanoma treatment | Sef Lucrări Dr. Andra Meșter |
| 09:05 – 09:25 | Metastatic malignant melanoma – state of the art and future perspectives | Conf. Dr. Laurentia Gales |
| 09:25 – 09:45 | Malignant Uveal Melanoma, Current and Future Therapies | Dr. Andreea Lazescu |
| 09:45 – 10:00 | Calf Sarcoma and 3D Interstitial Brahytherapy. Clinical Case Presentation and Literature Update | Dr. Amalia Constantinescu, Dr. Serban Marinescu, Dr. Ana-Maria Galca, Dr. Costina Diaconu, Dr. Georgiana Chirt, Dr. Fiz. Ancuta Elena Baciu, Fiz. Madalina Croitoriu, Fiz. Simona Lupu, Fiz. Diana Cipu |
| 10:00 – 10:30 | Update Sarcoma | Prof. Dr. Thomas Brodowicz |
| 10:30 – 11:00 | Guidelines Overview in Soft Tissue Sarcomas | Dr. Salvatore Provenzano |
| 11:00 – 11:20 | Immunotherapy in Sarcomas | Sef Lucrări Dr. Luiza Serbanescu |
| 11:20 – 11:35 | COFFEE BREAK | |
| 11:35 – 11:55 | The importance of minimally invasive lymphadenectomy through a 3D laparoscopic approach in the multimodal approach to penile tumors | Dr. Schitcu Vlad Horia, Dr. Munteanu Vlad Cristian, Dr. Popescu DS, Dr. Borz Mihnea Bogdan, Dr. Cojocaru I |
| 11:55 – 12:15 | Complex surgical situations in the pathology of renal tumors approached minimally invasively by 3D laparoscopy (partial nephrectomy on a single kidney, bilateral partial nephrectomies and excision of renal recurrences) | Dr. Schitcu Vlad Horia, Dr. Munteanu Vlad Cristian, Dr. Popescu DS, Dr. Borz Mihnea Bogdan, Dr. Cojocaru I, Dr. Tise AI, |
| 12:15 – 12:35 | Minimally invasive oncological surgery of lower urinary system tumors by 3D laparoscopy (invasive urothelial carcinoma of the bladder and prostatic adenocarcinoma) | Dr. Schitcu Vlad Horia, Dr. Munteanu Vlad Cristian, Popescu DS, Dr. Borz Mihnea Bogdan, Dr. Cojocaru I, Dr. Tise AI |
| 12:35 – 12:50 | Personalized therapy in prostate cancer: the “nonmolecular” contribution of the pathologist | Prof. Dr. Alis Dema, Vlad Dema |
| 12:50 – 13:20 | Satellite Symposium Astellas | Prof. Dr. Gabriel Kacso |
| 13:20 – 13:40 | Primary tumor irradiation in metastatic prostate cancer | Șef Lucrări Dr. Mihai Georgescu |
| 13:40 – 14:40 | LUNCH BREAK | |
| 14:40 – 14:55 | Metastatic RCC | Dr. Loredana Aracs |
| 14:55 – 15:15 | State of the Art and our Experience in IO/TKI First Line Treatment in Metastatic Renal Cell Carcinoma | Maria Cosnarovici, Manuela Pieszczoch, Iunia Patricia Cebotaru, Flaviu Andreicovici, Cristina Ligia Cebotaru |
| 15:15 – 15:35 | F18-PSMA PET / CT diagnosis of prostate cancer | Conf. Univ. Dr. Oreste Straciuc, Mihai Straciuc, Șef Lucrări Dr. Claudia Militaru |
| 15:35 – 15:50 | Satellite Symposium Sanofi – Immunotherapy: an alternative that exceeds the limits of classical treatment in CSCC | Dr. Anca Mihailov |
| 15:50 – 16:20 | Satellite Janssen – How to identify the mHSPC patient eligible for apalutamide | Dr. Amedeia Nita |
| 16:20 – 16:35 | Satellite Symposium Merck-Pfizer – Improved outcomes for RCC patients with the first IO +TKI combination reimbursed in Romania: BAVENCIO + axitinib JAVELIN RENAL 101 | Conf. Dr. Laurenția Galeș |
| 16:35 – 16:50 | Satellite Symposium Merck-Pfizer – Achieving extended survival by integrating 1st line maintenance treatment with an immune checkpoint inhibitor (ICI) for urothelial carcinoma patients: BAVENCIO JAVELIN BLADDER 100 | Dr. Andrei Ungureanu |
| 16:50 – 17:20 | Satellite Symposium AstraZeneca – Lynparza in prostate cancer – Dare to challenge! | Dr. Cristina Cebotaru |
| 17:20 – 17:50 | Satellite Symposium AstraZeneca – New hope for mCRPC patients | Prof. Dr. Gabriel Kacso |
| 17:50 – 18:05 | COFFEE BREAK | |
| 18:05 – 18:25 | Oligometastatic prostate cancer and SABR | Prof. Dr. Alina Mihai |
| 18:25 – 18:55 | New aspects in the diagnosis and radiotherapy treatment of prostate cancer | Prof. Dr. Anca Ligia Grosu |
| 18:55 – 19:20 | New therapeutic options in the adjuvant treatment of renal adenocarcinoma | Prof. Dr. Șerban Negru |
| 19:20 – 19:40 | Prostate Cancer Salvage Re-Irradiation – Real-World Data from an International Survey | Monica-Emilia Chirilă, Prasenjit Chaterjee, William Chen, Mohamed ElSisi, Konstantin Gordon, Benjamin Li, Wai-Kit Ma, Thandeka Mazibuko, Jure Murgic, David Antonio Martinez Perez, Mateusz Spalek, Gustavo Sarria, Sandra Turner, Piotr Wojcieszek,Thomas Zilli, Philip Poortmans, Mack Roach 3rd |
| 19:40 – 20:00 | Radiotherapy for Prostate Cancer Patients with Hip Prostheses: challenge or routine? | Felicia Constantina, Cristina Felicia Fetcu |
| 20:00 – 20:20 | Back to basics: the immediate and delayed effects of the covid 19 pandemic on the epidemiology and evolution of urinary tract cancers | Dr. Szilard Bereczki |
| 08:45 – 09:05 | The diagnostic value of PET/CT in early breast cancer | Dr. Sabau Claudia-Diana, Conf. Dr. Straciuc Oreste, Dr. Mihutiu Simona, Dr. Molnar Otto |
| 09:05 – 09:25 | The role of the radiologist in the multidisciplinary approach to breast cancer | Dr. Lisencu Carmen |
| 09:25 – 09:40 | The role of obesity and lifestyle in breast cancer patients prognosis | As. Univ. Dr. Iuliana Pantelimon |
| 09:40 – 10:10 | New drugs and radiation therapy in breast cancer | Dr. Valeria Masiello |
| 10:10 – 10:30 | Satellite Symposium AstraZeneca – Extend HER2+ expectations! | Conf. Dr. Laurentia Gales |
| 10:30 – 10:50 | Satellite Symposium Pfizer – #JoiningForces: clinical evidence & extensive practical experience in getting the optimal outcome in the treatment of ABC patients | Dr. Daniela Grecea |
| 10:50 – 11:20 | The difficult relationship between breast reconstruction with implant and radiotherapy | Prof. Dr. Alexandru Blidaru |
| 11:20 – 11:35 | COFFEE BREAK | |
| 11:35 – 12:45 | Breast Cancer Tumour Board for Daily Clinical Practice | Comisia Multidisciplinara de Tumori Mamare a Institutului Oncologic Prof. Dr. I. Chiricuta., Cluj Napoca – Dr. Nicoleta Antone, Dr Carmen Lisencu, Dr. Gabriela Morar – Bolba, Dr. Cosmin Lisencu, Dr. Maximilian Muntean, Dr. Bogdan Fetică, Dr. Adrian Trifa, Dr. Florina Pop, Dr. Marius Maxin, Dr. Daniela Martin |
| 12:45 – 13:00 | Is target volume coverage influenced by unstable bolus positioning in breast cancer patients? | Dr. Daniel Portik |
| 13:00 – 13:20 | Early onset of Chemo-radiotoxicity related cardiac events in breast cancer patients | As. Univ. Dr. Toma Radu Valeriu |
| 13:20 – 13:40 | An Analysis of the Effect of Concurrent Radiotherapy and CDK 4/6 Inhibitor in Metastatic Breast Cancer. Experience of a Referral Tertiary Centre | Conf. Dr. Laura Rebegea |
| 13:40 – 14:40 | LUNCH BREAK | |
| 14:40 – 15:10 | Robotic Mastectomy, Randomized Controlled Trial Comparing Open to Robotics | Dr. Antonio Toesca, Director of Breast Surgery Program, Candiolo Cancer institute, Turin Italy |
| 15:10 – 15:30 | Immunotherapy in neoadjuvant treatment of breast cancer. Are we ready for a paradigm shift? | Șef Lucrări Dr. Oana Trifănescu, Conf. Dr. Laurenția Galeș, Prof. Dr. Rodica Anghel |
| 15:30 – 15:45 | Satellite Symposium Eli Lilly – Verzenios – a new therapeutical approach in eBC HR+ HER2 | Dr. Daniela Grecea |
| 15:45 – 16:00 | Satellite Symposium Angelini – Maintaining the QoL of patients with highly emetogenic chemotherapy by optimizing emesis prophylaxis | Dr. Raluca Pătru |
| 16:00 – 16:40 | Tumor board in breast cancer – condition of the quality of oncological treatment | Conf. Dr. Laurențiu Simion, Ciprian Cirimbei |
| 16:40 – 17:05 | Gynecological cancers – advances in targeted molecular therapy and immunotherapy | Prof. Dr. Tudor Eliade Ciuleanu |
| 17:05 – 17:20 | Role and structure of psycho oncological intervention for gynecologic patients | Dr. Florina Pop |
| 17:20 – 17:40 | Preview on the recent European Guidelines for the Treatment of Gynecological Tumors | Dr. Ovidiu Coza |
| 17:40 – 17:55 | Evolving targets and treatment options in recurrent or metastatic cervical cancer | As. Univ. Dr. Maria Barbu |
| 17:55 – 18:10 | COFFEE BREAK | |
| 18:10 – 18:30 | Questionable indications in gynecology oncology guidelines | Conf. Dr. Alin Cristian Rancea |
| 18:30 – 18:50 | Satellite Symposium AstraZeneca – EVUSHELD as a COVID-19 pre-exposure prophylaxis (PrEP) solution complementary to vaccination, for vulnerable population | Dr. Amedeia Niță |
| 18:50 – 19:10 | Is there a place for surgery in local advanced cervical cancer, nowadays? | Conf. Dr. Silviu Voinea, Lacramioara Borangic, Ciprian Ianovici, Alexandru Blidaru, Cristian Bordea |
| 19:10 – 19:30 | Debates in treatment of early cervix cancer | Conf. Dr. Laura Rebegea |
| 19:30 – 19:50 | Advances in the management of endometrial cancer | Dr. Claudia Ordeanu |
| 19:50 – 20:05 | Vaginal dose reporting and evaluation in cervical cancer IGBT | Dr. Kirsch-Mangu Alexandra-Timea |
| 20:05 – 20:20 | Update in Ovarian Cancer | Dr. Aniela Platona |
| 08:45 – 09:05 | The diagnostic value of PET/CT in early breast cancer | Dr. Sabau Claudia-Diana, Conf. Dr. Straciuc Oreste, Dr. Mihutiu Simona, Dr. Molnar Otto |
| 09:05 – 09:25 | The role of the radiologist in the multidisciplinary approach to breast cancer | Dr. Lisencu Carmen |
| 09:25 – 09:40 | The role of obesity and lifestyle in breast cancer patients prognosis | As. Univ. Dr. Iuliana Pantelimon |
| 09:40 – 10:10 | New drugs and radiation therapy in breast cancer | Dr. Valeria Masiello |
| 10:10 – 10:30 | Satellite Symposium AstraZeneca – Extend HER2+ expectations! | Conf. Dr. Laurentia Gales |
| 10:30 – 10:50 | Satellite Symposium Pfizer – #JoiningForces: clinical evidence & extensive practical experience in getting the optimal outcome in the treatment of ABC patients | Dr. Daniela Grecea |
| 10:50 – 11:20 | The difficult relationship between breast reconstruction with implant and radiotherapy | Prof. Dr. Alexandru Blidaru |
| 11:20 – 11:35 | COFFEE BREAK | |
| 11:35 – 12:45 | Breast Cancer Tumour Board for Daily Clinical Practice | Comisia Multidisciplinara de Tumori Mamare a Institutului Oncologic Prof. Dr. I. Chiricuta., Cluj Napoca – Dr. Nicoleta Antone, Dr Carmen Lisencu, Dr. Gabriela Morar – Bolba, Dr. Cosmin Lisencu, Dr. Maximilian Muntean, Dr. Bogdan Fetică, Dr. Adrian Trifa, Dr. Florina Pop, Dr. Marius Maxin, Dr. Daniela Martin |
| 12:45 – 13:00 | Is target volume coverage influenced by unstable bolus positioning in breast cancer patients? | Dr. Daniel Portik |
| 13:00 – 13:20 | Early onset of Chemo-radiotoxicity related cardiac events in breast cancer patients | As. Univ. Dr. Toma Radu Valeriu |
| 13:20 – 13:40 | An Analysis of the Effect of Concurrent Radiotherapy and CDK 4/6 Inhibitor in Metastatic Breast Cancer. Experience of a Referral Tertiary Centre | Conf. Dr. Laura Rebegea |
| 13:40 – 14:40 | LUNCH BREAK | |
| 14:40 – 15:10 | Robotic Mastectomy, Randomized Controlled Trial Comparing Open to Robotics | Dr. Antonio Toesca, Director of Breast Surgery Program, Candiolo Cancer institute, Turin Italy |
| 15:10 – 15:30 | Immunotherapy in neoadjuvant treatment of breast cancer. Are we ready for a paradigm shift? | Șef Lucrări Dr. Oana Trifănescu, Conf. Dr. Laurenția Galeș, Prof. Dr. Rodica Anghel |
| 15:30 – 15:45 | Satellite Symposium Eli Lilly – Verzenios – a new therapeutical approach in eBC HR+ HER2 | Dr. Daniela Grecea |
| 15:45 – 16:00 | Satellite Symposium Angelini – Maintaining the QoL of patients with highly emetogenic chemotherapy by optimizing emesis prophylaxis | Dr. Raluca Pătru |
| 16:00 – 16:40 | Tumor board in breast cancer – condition of the quality of oncological treatment | Conf. Dr. Laurențiu Simion, Ciprian Cirimbei |
| 16:40 – 17:05 | Gynecological cancers – advances in targeted molecular therapy and immunotherapy | Prof. Dr. Tudor Eliade Ciuleanu |
| 17:05 – 17:20 | Role and structure of psycho oncological intervention for gynecologic patients | Dr. Florina Pop |
| 17:20 – 17:40 | Preview on the recent European Guidelines for the Treatment of Gynecological Tumors | Dr. Ovidiu Coza |
| 17:40 – 17:55 | Evolving targets and treatment options in recurrent or metastatic cervical cancer | As. Univ. Dr. Maria Barbu |
| 17:55 – 18:10 | COFFEE BREAK | |
| 18:10 – 18:30 | Questionable indications in gynecology oncology guidelines | Conf. Dr. Alin Cristian Rancea |
| 18:30 – 18:50 | Satellite Symposium AstraZeneca – EVUSHELD as a COVID-19 pre-exposure prophylaxis (PrEP) solution complementary to vaccination, for vulnerable population | Dr. Amedeia Niță |
| 18:50 – 19:10 | Is there a place for surgery in local advanced cervical cancer, nowadays? | Conf. Dr. Silviu Voinea, Lacramioara Borangic, Ciprian Ianovici, Alexandru Blidaru, Cristian Bordea |
| 19:10 – 19:30 | Debates in treatment of early cervix cancer | Conf. Dr. Laura Rebegea |
| 19:30 – 19:50 | Advances in the management of endometrial cancer | Dr. Claudia Ordeanu |
| 19:50 – 20:05 | Vaginal dose reporting and evaluation in cervical cancer IGBT | Dr. Kirsch-Mangu Alexandra-Timea |
| 20:05 – 20:20 | Update in Ovarian Cancer | Dr. Aniela Platona |
| 09:00 – 09:20 | Updates in radiotherapy in postoperative setting for patients with NSCLC | Prof. Dr. Rodica Anghel |
| 09:20 – 09:40 | Advanced non-small cell lung carcinomas with rare mutations | Prof. Dr. Tudor Ciuleanu |
| 09:40 – 10:00 | Minimally invasive thoracic surgery in lung neoplasms. | Șef. Lucrări Dr. Natalia Motas |
| 10:00 – 10:30 | Extending immunotherapy in early stage NSCLC. What are the evidences ? | Dr. Mircea Dediu |
| 10:30 – 11:00 | Discordant between the initial diagnosis and the final diagnosis in NSCLC. The experience of a single diagnostic center. | Ovidiu Pop, Ana Jakob, Pascalau Andrei, Stef Naomi, Stefanet Ghenadie |
| 11:00 – 11:20 | COFFEE BREAK | |
| 11:20 – 11:40 | Predictive biomarkers for immunotherapy: which biomarker to use across histologies and clinical settings? | Dr. Mihaela Pasca-Fenesan |
| 11:40 – 12:00 | The use of stereotactic body radiotherapy in oligometastatic lung cancer | Dr. Claudiu Hopirtean |
| 12:00 – 12:30 | Satellite Symposium Pfizer – Is it time to reimagine the treatment goals for patients with NSCLC ALK+ patients? Benefits of Lorviqua® (lorlatinib) | Prof. Dr. Tudor Eliade Ciuleanu |
| 12:30 – 13:20 | Satellite Symposium AstraZeneca – Treatment Standards in Lung Cancer | Dr. Andra Meșter, Dr. Andrei Ungureanu |
| 13:20 – 13:35 | Satellite Symposium Bristol Myers Squibb – Built to Last, O+Y in MM and RCC | Dr. Mircea Dediu |
| 13:35 – 13:50 | Satellite Symposium Bristol Myers Squibb – Opdivo+Yervoy+2 cycles of chemotherapy: a new perspective in 1L NSCLC | Prof. Dr. Tudor Eliade Ciuleanu |
| 13:50 – 14:10 | Satellite Symposium Varian – Quality and precision in radiotherapy treatments | |
| 14:10 – 15:10 | LUNCH BREAK | |
| 15:10 – 15:35 | Nutritional management in radiochemotherapy of head and neck cancers | Dr. Ana-Maria Ilie, Andreea Ciobanu, Mihaela Dumitru, Florentina Lacatus, Marius Paduraru, Conf. Dr. Laura Rebegea |
| 15:35 – 16:00 | Multimodal therapeutic approach and palliative care for head and neck cancer. | As. Univ. Dr. Roxana Rahnea |
| 16:00 – 16:35 | Satellite Symposium MSD – Revolutionizing r/M HNSCC cancer care with Keytruda in the 1st line | Dr. Renata Zahu, Dr. Andra Mester |
| 16:35 – 17:05 | The rationale of offline radiotherapy in head and neck cancer and workflow | Dr. Hale Basak Çağlar |
| 17:05 – 17:25 | COFFEE BREAK | |
| 17:25 – 17:45 | Clinical implication of the new classification of gliomas – neurologist point of view | Dr. Dan Mitrea, Laurentia Gales, Rodica Anghel Oana Trifanescu |
| 17:45 – 18:05 | Treatment implication of new classification of gliomas – oncologist point of view | Șef Lucrări Dr. Oana Trifănescu, Laurentia Gales, Rodica Anghel, Dan Mitrea |
| 18:05 – 18:25 | Updates of radiotherapy in gliomas – radiotherapist point of view | Șef Lucrări Dr. Mihai Georgescu |
Lupău, C.*, Mihuțiu, S.**,Pătcaș, E*., Lupău, A.***
*Clinical Emergency County Hospital Oradea
**University of Oradea, Faculty of Medicine and Pharmacy
***UBB, Faculty of Psychology and Educational Sciencies
Todor Nicolae, Viorica Nagy, Bondei Irina
| 09:00 – 09:20 | Adjuvant chemotherapy in locally advanced rectal cancer. Where do we stand? | Dr. Sebastian Curcean, Dr. Alina – Simona Muntean |
| 09:20 – 09:40 | Current Trends in the Treatment of Locally Advanced Rectal Cancer | Dr. Alina – Simona Muntean |
| 09:40 – 10:00 | Association of radiotherapy with immunotherapy in digestive cancers | Șef Lucrări Dr. Radu Mitrică, Dr. Diana Mitrea |
| 10:00 – 10:20 | Imunotherapy and microbiome | Șef Lucrări Dr. Anca Zgură |
| 10:20 – 10:40 | Fluctuation of the CEA marker in the follow-up of curatively treated colon cancer | Fekete Zsolt, Muntean Alina-Simona, Lazar Gabriel, Vlad Catalin, Eniu Dan, Bochis Ovidiu |
| 10:40 – 10:55 | Advances in neuroendocrine pancreatic tumor surgery – is the search for minimal invasiveness the main concern? | Conf. Dr. Octav Ginghina |
| 10:55 – 11:10 | Educational Symposium Servier Pharma – Long Term survivors in mPDAC | Dr. Radu Vidra |
| 11:10 – 11:30 | COFFEE BREAK | |
| 11:30 – 11:50 | Pelvectomy – a constantly changing technique | Vlad Rotaru, Ciprian Cirimbei, Laurențiu Simion, Cristina Ștefan, Bogdan Tănase, Dan Luca, Elena Chițoran |
| 11:50 – 12:10 | Is minimally invasive approach suited for surgical management of esophageal tumors? | Dr. Bogdan Tănase |
| 12:10 – 12:30 | Multivisceral resections with pancreatic involvement | Ciprian Cirimbei, Claudiu Daha, Laurențiu Simion |
| 12:30 – 12:50 | Complete response in rectal cancer following neoadjuvant therapy – what to do? | Claudiu Daha, Hortensia Moisa, Virgiliu Prunoiu, Laurențiu Simion |
| 12:50 – 13:10 | Educational Symposium Servier Pharma – Optimization and Management of Treatment in mCRC | Prof. Dr. Tudor Eliade Ciuleanu |
| 13:10 – 13:30 | 7 years of Radiotherapy Oncohelp | Dr. Anca Croitoru, Ilie Bogdan |
| 13:30 – 13:50 | Inflammatory Microenvironment and RAS/RAF Genetic Mutations Correlations in Colorectal Cancer Patients: a Quest for Dissemination Patterns and Predictors | Conf. Dr. Liviu Bilteanu |
| 13:50 – 15:10 | LUNCH BREAK | |
| 15:10 – 15:30 | Satellite Symposium Elekta – Experience in clinical practice with Elekta Unity – MR Linac | Prof. Filippo Alongi MD – Head of Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Cancer Care Center, Negrar (Verona), Italy |
| 15:30 – 15:50 | Novel radiobiology in the era of immunotherapy: where do we stand?” | Dr. Brie Ioana |
| 15:50 – 16:10 | Tumor microenvironment: implications for therapeutic response | Dr. Virag Piroska |
| 16:00 – 16:25 | Cancer immunogram – a useful tool in therapy tailoring and prediction of outcome | Dr. Perde-Schrepler Maria |
| 16:25 – 16:50 | Expression of cancer stem cell markers in the evolution of different skin cancer subtypes | Dr. Andercou Otilia |
| 16:50 – 17:10 | COFFEE BREAK | |
| 17:10 – 17:30 | Beta-glucan-based drug delivery system and its potential application in targeting tumor associated immune cells | Dr. Cherecheș Gabriela |
| 17:30 – 18:10 | Exploring the role of tumor microenvironment in driving CSC maintenance in breast cancer | Oana Baldasici, Andrei Roman, Carmen Lisencu, Simona Visan, Olga Soritau, Daniel Cruceriu, Laura Maja, Bogdan Pop, Bogdan Fetica, Andrei Cismaru, Loredana Balacescu, Ovidiu Balacescu, Laurian Vlase, Daniel Irimia, Aman Russom, Oana Tudoran |
| 18:10 – 18:30 | Role of liquid biopsy-delivered miRNAs in liver metastasis prediction and chemotherapy response among advanced-stage colorectal cancer patients | Ovidiu Balacescu, Daniel Sur, Rares Buiga, Simona Visan, Alexandru Irimie, Calin Cainap, Loredana Balacescu |
| 18:30 – 18:50 | Circulating exosomal miRNAs as predictors of pathological response to neoadjuvant therapy in breast cancer patients | Oana Tudoran, Oana Baldasici, Daniel Cruceriu, Andrei Roman, Carmen Lisencu, Bogdan Fetica, Andrei Cismaru, Valentina Pileczki, Loredana Balacescu, Ovidiu Balacescu |
